← All organizations
Highest phase reached
Phase 2
First clinical trial
Jun 19, 2017Last known activity
Nov 1, 2022
Timeline
1990s
- Dec 1, 1999
Cellectis S.A.— Founded
2010s
- Sep 10, 2010
Cyto Pulse Sciences, Inc.— Acquired
- Sep 15, 2011
Cellartis— Acquired
- Dec 30, 2013
Ectycell SASU— Acquired
2020s
- Jan 17, 2023
Calyxt— Acquired
Drugs by trial phase (9 distinct, 9 trials)
Phase 2 (2 own, 3 via acquisition)
Phase 1 (3 own, 1 via acquisition)
Indications
Subsidiaries (4 direct, 4 total across the full acquisition tree)
Recent trials (8)
- NCT05607420Lead sponsorPhase 1/Phase 2Nov 1, 2022
- NCT04142619Lead sponsorPhase 1Oct 25, 2019
- NCT04150497Lead sponsorPhase 1Oct 17, 2019
- NCT04106076Lead sponsorPhase 1Jul 11, 2019
- NCT03203369Lead sponsorPhase 1Jun 28, 2017
- NCT03203369Study directorPhase 1Jun 28, 2017
- NCT03190278Lead sponsorPhase 1Jun 19, 2017
- NCT03190278Study directorPhase 1Jun 19, 2017
Details
- Founded
- Paris, FR Dec 1, 1999
- Last known activity
- Nov 1, 2022